Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K, filed on February 22, 2022, reports the fourth quarter results for the period ending February 22, 2022. The filing serves to distribute a press release (Exhibit 99.1) and a complete overview of financial figures for the fourth quarter and full year 2021 (Exhibit 99.2).
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Exhibits 99.1 and 99.2. The Company utilizes the following non-GAAP measures to supplement IFRS reporting:
- EBITDA (Operating income excluding interest, taxes, depreciation, and amortization)
- Adjusted EBITDA
- Free Cash Flow
- Net Leverage Ratio (Net debt to adjusted EBITDA)
- Results presented in constant currency
Material Changes and Comparisons
The filing text does not provide specific data regarding material changes versus the prior comparable period. It notes that reconciliations for non-GAAP measures to IFRS measures are included in the attached financial statements, and constant currency adjustments are inherent in the press release disclosure.
Guidance, Outlook, and Risks
The filing text does not explicitly state guidance, outlook, or specific risk factors. It includes a standard disclaimer that the attached exhibits are furnished and not "filed" for purposes of Section 18 of the Exchange Act, nor are they incorporated by reference into other filings. The Company asserts that non-GAAP measures are provided to enhance understanding of performance and prospects but should not be considered superior to GAAP measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2021 revenue and profit figures.
- Examine Exhibit 99.2 for the detailed reconciliation of non-GAAP measures (EBITDA, Free Cash Flow) to IFRS standards.
- Verify the Net Leverage Ratio and Free Cash Flow calculations in the attached financial overview.
- Check the press release for any updated full-year 2022 guidance or strategic outlook not detailed in this cover letter.